Gene · 5476
Papers2,520
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,520
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Biomarker Study in Patients with GBA1-Parkinson's Disease and Healthy Controls. | Mov Disord | 2023 | 36916660 | PubTator, text mining | PubMed |
| A Mouse Systems Genetics Approach Reveals Common and Uncommon Genetic Modifiers of Hepatic Lysosomal Enzyme Activities and Glycosphingolipids. | Int J Mol Sci | 2023 | 36902345 | PubTator, text mining | PubMed |
| Auditory-perceptual evaluation of voice: comparing different speech tasks to identify children with and without laryngeal lesions. | Codas | 2023 | 36888744 | PubTator, text mining | PubMed |
| Sphingolipids in neurodegenerative diseases. | Front Neurosci | 2023 | 36875645 | PubTator, text mining | PubMed |
| Joint effect of highly-sensitive cardiac troponin T and ankle-brachial index on incident cardiovascular events: The MESA and CHS. | Am J Prev Cardiol | 2023 | 36873803 | PubTator, text mining | PubMed |
| Severe dilated cardiomyopathy as an unusual clinical presentation in an infant with sialidosis type II. | JIMD Rep | 2023 | 36873090 | PubTator, text mining | PubMed |
| Bulk and single-cell characterisation of the immune heterogeneity of atherosclerosis identifies novel targets for immunotherapy. | BMC Biol | 2023 | 36855107 | PubTator, text mining | PubMed |
| Euphejolkinolide A, a new ent-abietane lactone from Euphorbia peplus L. with promising biological activity in activating the autophagy-lysosomal pathway. | Heliyon | 2023 | 36852065 | PubTator, text mining | PubMed |
| Cerebral Small Vessel Disease-Related Dementia: More Questions Than Answers. | Stroke | 2023 | 36848423 | PubTator, text mining | PubMed |
| Polysaccharides' Structures and Functions in Biofilm Architecture of Antimicrobial-Resistant (AMR) Pathogens. | Int J Mol Sci | 2023 | 36835442 | PubTator, text mining | PubMed |
| Cannabinoids Transmogrify Cancer Metabolic Phenotype via Epigenetic Reprogramming and a Novel CBD Biased G Protein-Coupled Receptor Signaling Platform. | Cancers (Basel) | 2023 | 36831374 | PubTator, text mining | PubMed |
| Restoring Epigenetic Reprogramming with Diet and Exercise to Improve Health-Related Metabolic Diseases. | Biomolecules | 2023 | 36830687 | PubTator, text mining | PubMed |
| Developing multifunctional crops by engineering Brassicaceae glucosinolate pathways. | Plant Commun | 2023 | 36823985 | PubTator, text mining | PubMed |
| Prognosis and clinical features analysis of EMT-related signature and tumor Immune microenvironment in glioma. | J Med Biochem | 2023 | 36819132 | PubTator, text mining | PubMed |
| Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer Consortium. | Lancet Reg Health Am | 2023 | 36818595 | PubTator, text mining | PubMed |
| Sorting nexin 10 sustains PDGF receptor signaling in glioblastoma stem cells via endosomal protein sorting. | JCI Insight | 2023 | 36795488 | PubTator, text mining | PubMed |
| Structural and functional analysis of natural capsid variants suggests sialic acid-independent entry of BK polyomavirus. | Cell Rep | 2023 | 36790933 | PubTator, text mining | PubMed |
| Role of cathepsin D induced by Porphyromonas gingivalis lipopolysaccharide in periodontitis. | Eur J Oral Sci | 2023 | 36788303 | PubTator, text mining | PubMed |
| Deciphering the Kidney Matrisome: Identification and Quantification of Renal Extracellular Matrix Proteins in Healthy Mice. | Int J Mol Sci | 2023 | 36769148 | PubTator, text mining | PubMed |
| Molecular Pathways of Diabetic Kidney Disease Inferred from Proteomics. | Diabetes Metab Syndr Obes | 2023 | 36760602 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5476/papers?page=15